Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumour escape: antitumour effectors too much of a good thing?
Graham Pawelec
Cancer Immunology Immunotherapy (2004) Vol. 53, Iss. 3, pp. 262-274
Closed Access | Times Cited: 87

Showing 26-50 of 87 citing articles:

Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma
Elissaveta Naumova, A. Mihaylova, Milena Ivanova, et al.
Cancer Immunology Immunotherapy (2006) Vol. 56, Iss. 1, pp. 95-100
Open Access | Times Cited: 47
T-cell dysregulation caused by chronic antigenic stress: the role of CMV in immunosenescence?
Graham Pawelec, Cécile Gouttefangeas
Aging Clinical and Experimental Research (2006) Vol. 18, Iss. 2, pp. 171-173
Closed Access | Times Cited: 44
Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands
Rafael Solana, Javier G. Casado, Elena Delgado, et al.
Cancer Immunology Immunotherapy (2006) Vol. 56, Iss. 1, pp. 101-109
Closed Access | Times Cited: 39
Immunosuppression in Melanoma Immunotherapy: Potential Opportunities for Intervention
Gregory Lizée, Laszlo Radvanyi, Willem W. Overwijk, et al.
Clinical Cancer Research (2006) Vol. 12, Iss. 7, pp. 2359s-2365s
Closed Access | Times Cited: 39
Induction of NKG2D Ligands and Subsequent Enhancement of NK Cell-mediated Lysis of Cancer Cells by Arsenic Trioxide
Jooyoung Kim, Jae‐Ho Bae, Sang Hwa Lee, et al.
Journal of Immunotherapy (2008) Vol. 31, Iss. 5, pp. 475-486
Closed Access | Times Cited: 32
In Melanoma Changes of Immature and Mature Dendritic Cell Expression Correlate with Tumor Thickness: An Immunohistochemical Study
Oriana Simonetti, Gaia Goteri, Guendalina Lucarini, et al.
International Journal of Immunopathology and Pharmacology (2007) Vol. 20, Iss. 2, pp. 325-333
Closed Access | Times Cited: 32
Immunotherapy and immunoselection – tumour escape as the final hurdle
Graham Pawelec
FEBS Letters (2004) Vol. 567, Iss. 1, pp. 63-66
Open Access | Times Cited: 32
Prognostic Significance of RCAS1 Expression in Relation to the Infiltration of Dendritic Cells and Lymphocytes in Patients with Esophageal Carcinoma
Shunichi Tsujitani, Hiroaki Saito, Shinichi Oka, et al.
Digestive Diseases and Sciences (2007) Vol. 52, Iss. 2, pp. 549-554
Closed Access | Times Cited: 26
Immunoepigenetics: the unseen side of cancer immunoediting
Anastasios E. Germenis, Vaios Karanikas
Immunology and Cell Biology (2006) Vol. 85, Iss. 1, pp. 55-59
Closed Access | Times Cited: 24
Rebuilding immunity in cancer patients
Stanimir Vuk‐Pavlović
Blood Cells Molecules and Diseases (2007) Vol. 40, Iss. 1, pp. 94-100
Open Access | Times Cited: 22
Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion
Marie K. Brimnes, Anne Ortved Gang, Marco Donia, et al.
Cancer Immunology Immunotherapy (2012) Vol. 61, Iss. 8, pp. 1221-1231
Open Access | Times Cited: 17
DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand?
Sarfraz Ahmad, Paul Sweeney, Gerald C. O Sullivan, et al.
Genetic Vaccines and Therapy (2012) Vol. 10, Iss. 1
Open Access | Times Cited: 17
Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemia
Mhairi Copland, Alasdair R. Fraser, Simon J. Harrison, et al.
Cancer Immunology Immunotherapy (2004) Vol. 54, Iss. 4, pp. 297-306
Open Access | Times Cited: 24
RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi
Eijun Itakura, Rongrong Huang, Duan‐Ren Wen, et al.
Modern Pathology (2008) Vol. 21, Iss. 3, pp. 326-333
Open Access | Times Cited: 18
Transforming growth factor-β-mediated signaling in T lymphocytes impacts on prostate-specific immunity and early prostate tumor progression
Kerrilyn R. Diener, Anthony E. Woods, Jim Manavis, et al.
Laboratory Investigation (2008) Vol. 89, Iss. 2, pp. 142-151
Open Access | Times Cited: 17
Therapeutic cancer vaccines: a long and winding road to success
Constantin N. Baxevanis, Michael Papamichail, Sonia A. Perez
Expert Review of Vaccines (2013) Vol. 13, Iss. 1, pp. 131-144
Closed Access | Times Cited: 13
Continuous Presence of Th1 Conditions Is Necessary for Longer Lasting Tumor-Specific CTL Activity in Stimulation Cultures With PBL
Subhasis Chattopadhyay, Nitya G. Chakraborty
Human Immunology (2005) Vol. 66, Iss. 8, pp. 884-891
Closed Access | Times Cited: 19
Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy
Alessandra da Cunha, Márcia Antoniazi Michelin, Eddie Fernando Cândido Murta
Immunology Letters (2016) Vol. 177, pp. 25-37
Closed Access | Times Cited: 11
The use of inflammation by tumor cells
José Ignacio Arias, María‐Angeles Aller, Jaime Árias
Cancer (2005) Vol. 104, Iss. 2, pp. 223-228
Closed Access | Times Cited: 18
Clinical Model: Interferons Activate Human Monocytes to An Eradicative Tumor Cell LevelIn Vitro
Samuel Baron, Jessica Hernandez‐Rodriguez, Joseph Bekisz, et al.
Journal of Interferon & Cytokine Research (2007) Vol. 27, Iss. 2, pp. 157-164
Closed Access | Times Cited: 14
Cellular Immunotherapy for Neuroblastoma: A Review of Current Vaccine and Adoptive T Cell Therapeutics
Chrystal U. Louis, M.K. Brenner
Current Pharmaceutical Design (2009) Vol. 15, Iss. 4, pp. 424-429
Open Access | Times Cited: 13
Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor
Joel Shilyansky, Paulette Jacobs, Kara Doffek, et al.
Journal of Pediatric Surgery (2007) Vol. 42, Iss. 1, pp. 54-61
Closed Access | Times Cited: 13
In Vivo Tumor Secretion Probing Via Ultrafiltration and Tissue Chamber:Implication for Anti-Cancer Drugs Targeting Secretome
Chun‐Ming Huang, Teruaki Nakatsuji, Yu-Tseung Liu, et al.
Recent Patents on Anti-Cancer Drug Discovery (2008) Vol. 3, Iss. 1, pp. 48-54
Open Access | Times Cited: 13
Role of the microenvironment in the tumourigenesis of microsatellite unstable and MUTYH-associated polyposis colorectal cancers
Noel F.C.C. de Miranda, Frederik J. Hes, Tom van Wezel, et al.
Mutagenesis (2012) Vol. 27, Iss. 2, pp. 247-253
Open Access | Times Cited: 11
Paneling human thyroid cancer cell lines for candidate proteins for targeted anti‐angiogenic therapy
Sebastian Hoffmann, A. Wunderlich, İlhan Çelik, et al.
Journal of Cellular Biochemistry (2006) Vol. 98, Iss. 4, pp. 954-965
Open Access | Times Cited: 14

Scroll to top